Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Pulsed Acoustic Device Hastens Tattoo Removal and Fading

By HospiMedica International staff writers
Posted on 04 Apr 2019
An innovative laser ancillary device use rapid pulsed acoustic shockwaves to accelerate the removal of unwanted tattoos.

The Soliton (Houston, TX, USA) Rapid Acoustic Pulse (RAP) device is designated as an accessory to a 1064 nm Q-Switched laser for black ink tattoo removal on the arms, legs, and torso in Fitzpatrick Skin Type I-III individuals. More...
RAP allows for multiple passes of a Q-Switched laser during a single treatment session; after the initial laser pass has been made and vacuoles have formed, the RAP Device is applied immediately afterward. Within seconds, the RAP’s acoustic waves remove the vacuoles, as well as further dispersing the ink pigment from the macrophages.

Another laser pass is now immediately possible and may be followed by another RAP pass, and so on. With the new approach, the RAP device enables multiple passes in a single treatment session, resulting in accelerated fading when compared to stand-alone laser treatment, and allowing tattoo removal to be completed in just two to three office visits. According to the company, RAP shockwave technology is also capable of inducing mechanical stress in fibroblasts, leads to new collagen growth, which could help reduce skin laxity and the appearance of cellulite.

“The human trials provided evidence of the potential for the RAP technology to accelerate tattoo fading,” said Chris Capelli, MD, President and CEO of Soliton. “The combination treatment of the RAP device and a laser outperformed a laser alone, showing an average of 80% fading after only two visits, versus 44% fading for the laser alone. After three Soliton multi-pass treatments, 100% of the treated tattoos had a complete (76-100% faded) response; in comparison, only 17% of the tattoos treated with the laser only had a complete response."

“Our strategy is a razor/razorblade model with consumable products for single-use applications, generating recurring revenue,” concluded Dr. Capelli. “We believe this business model will serve the company and our shareholders well as we enter into the tattoo removal segment, and eventually into additional aesthetics markets. We are excited about the prospects for expanding the use of our RAP technology to address new markets and other aesthetic issues.”

The current standard of care for tattoo removal is to use a Q-switched (pulsed) laser to ablate the tattoo ink particles into pieces small enough for the body's natural processes to remove them. Unfortunately, it is highly inefficient, requiring up to 10 or more office visits to achieve acceptable results.

Related Links:
Soliton


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Rapid Sepsis Test
SeptiCyte RAPID
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
image: Principles of SMEAR-ULM. (Lai, Y., Argüello, A.N., Liu, M. et al., Nature Sensors (2026). DOI: 10.1038/s44460-026-00078-4)

“Intelligent Tattoo” Method Detects Early Melanoma Signals

Melanoma is a lethal skin cancer in which earlier detection drives better outcomes. Current evaluation relies on visual inspection followed by biopsy, which can miss nascent lesions and lead to unnecessary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.